Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-308382
Filing Date
2017-10-12
Accepted
2017-10-12 07:10:32
Documents
6
Effectiveness Date
2017-10-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A d462898ddefa14a.htm DEFA14A 42664
2 GRAPHIC g4628982.jpg GRAPHIC 926
3 GRAPHIC g4628983.jpg GRAPHIC 918
4 GRAPHIC g4628983a.jpg GRAPHIC 2805
5 GRAPHIC g4628984.jpg GRAPHIC 921
6 GRAPHIC g4628985.jpg GRAPHIC 916
  Complete submission text file 0001193125-17-308382.txt   53192
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 171133763
SIC: 2835 In Vitro & In Vivo Diagnostic Substances